Clinical Trial

Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
In this study, we are trying to see if vitamin B6 can minimize the amplified blood pressure response to exercise following ischemia-reperfusion injury. We are interested in a protein called P2X3, of which function can be blocked by vitamin B6, in the neurons of our nervous system. It is very important for blood pressure regulation. We would like to see if the P2X3 plays a role in patients' rising blood pressure during exercise. The results of the proposed studies will provide a base for those two potential economic and non-invasive inventions to improve the overall health and well-being of PAD patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-11; most recent amendment 2026-03-16.
Trial Details
NCT Number NCT06369350
Lead Sponsor Milton S. Hershey Medical Center
Collaborators: American Heart Association
Conditions Ischemia Reperfusion Injury, Peripheral Artery Disease
Enrollment 30 participants
Start Date 2027-12
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-17